Ashraf Mohamed El-Saghier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ashraf Mohamed El-Saghier has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ali A. Abdelrahman
Department of Microbiology and Immunology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt
1 shared publication - Ashraf Elsaghier
Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt
1 shared publication Asmaa Mahmoud Farag
Pediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt
1 shared publication- Emad El-Deen Mahmoud Hammad
Pediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt
1 shared publication - Eman Ahmed Abd-Alrahman
Medical Microbiology and Immunology, Faculty of Medicine for Girls, Al-Azhar University, Assiut 71526, Egypt
1 shared publication - Eman Ramadan Mohamed
Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Assiut 71526, Egypt
1 shared publication
Latest Publications
- Open Access
- 9 June 2026
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 16 (1) , 35
Noninvasive indices associated with esophageal varices in children with portal hypertension: a single-center exploratory diagnostic accuracy study
Background: Esophageal varices (EV) are a major complication of pediatric portal hypertension. Data on the diagnostic accuracy of noninvasive indices for identifying EV in Egyptian children remain scarce. This exploratory study aimed to evaluate the association between readily available clinical, laboratory, and sonographic parameters and the presence of EV in children with portal hypertension at a tertiary referral center. Patients and methods: In this cross-sectional diagnostic accuracy study, 41 children with chronic liver disease, extrahepatic portal vein obstruction (EHPVO), or cirrhosis were consecutively enrolled at Assiut University Children Hospital between January 2022 and January 2023. All participants underwent clinical evaluation, laboratory testing, abdominal and Doppler ultrasonography, and calculation of noninvasive indices including platelet count, spleen-size z -score, platelet/spleen ratio, and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI). Esophagogastroduodenoscopy (EGD) served as the reference standard for diagnosis and grading of varices. Results: Esophageal varices were detected in 31 children (75.6%). Compared with those without varices, affected children had significantly lower hemoglobin (9.4 ± 1.8 vs. 11.9 ± 1.3 g/dL, p = 0.027), platelet counts (139.7 ± 87.6 vs. 245.7 ± 61.0 × 10⁹/L, p = 0.001), and albumin (2.9 ± 0.6 vs. 3.9 ± 0.3 g/dL, p < 0.001), with prolonged prothrombin time (14.9 ± 2.9 vs. 12.6 ± 1.1 s, p = 0.021). Sonographic findings showed smaller liver size (9.8 ± 1.4 vs. 12.0 ± 1.9 cm, p = 0.002), larger spleen size (128.2 ± 3.7 vs. 88.1 ± 1.6 mm, p = 0.002), and higher APRI scores (1.69 ± 1.65 vs. 0.28 ± 0.16, p = 0.011). On multivariate analysis, splenomegaly (aOR 8.45, 95% CI 3.21–22.28), elevated APRI (aOR 5.10, 95% CI 2.30–11.30), and thrombocytopenia (aOR 4.82, 95% CI 1.95–11.92) were associated with EV in the exploratory multivariate model, though confidence intervals were wide, reflecting the small sample size. Spleen length ≥ 120 mm demonstrated the highest area under the receiver operating characteristic curve (AUC 0.88; bootstrap-corrected 0.86). In an exploratory etiology-stratified analysis, APRI was significantly associated with EV in the cirrhosis subgroup ( n = 25) but not in the EHPVO subgroup ( n = 16). Conclusion: In this single-center exploratory study, splenomegaly, thrombocytopenia, and elevated APRI showed significant associations with the presence of EV in children with portal hypertension. These findings suggest that readily available clinical and laboratory parameters may have potential utility for risk stratification; however, the small sample size, high disease prevalence, and absence of external validation preclude definitive conclusions. Prospective multicenter studies with larger, etiology-stratified cohorts are needed to confirm these observations and establish reliable diagnostic thresholds.
- 9 June 2026
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 16 (1) , 35
Open AccessNoninvasive indices associated with esophageal varices in children with portal hypertension: a single-center exploratory diagnostic accuracy study
Background: Esophageal varices (EV) are a major complication of pediatric portal hypertension. Data on the diagnostic accuracy of noninvasive indices for identifying EV in Egyptian children remain scarce. This exploratory study aimed to evaluate the association between readily available clinical, laboratory, and sonographic parameters and the presence of EV in children with portal hypertension at a tertiary referral center. Patients and methods: In this cross-sectional diagnostic accuracy study, 41 children with chronic liver disease, extrahepatic portal vein obstruction (EHPVO), or cirrhosis were consecutively enrolled at Assiut University Children Hospital between January 2022 and January 2023. All participants underwent clinical evaluation, laboratory testing, abdominal and Doppler ultrasonography, and calculation of noninvasive indices including platelet count, spleen-size z -score, platelet/spleen ratio, and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI). Esophagogastroduodenoscopy (EGD) served as the reference standard for diagnosis and grading of varices. Results: Esophageal varices were detected in 31 children (75.6%). Compared with those without varices, affected children had significantly lower hemoglobin (9.4 ± 1.8 vs. 11.9 ± 1.3 g/dL, p = 0.027), platelet counts (139.7 ± 87.6 vs. 245.7 ± 61.0 × 10⁹/L, p = 0.001), and albumin (2.9 ± 0.6 vs. 3.9 ± 0.3 g/dL, p < 0.001), with prolonged prothrombin time (14.9 ± 2.9 vs. 12.6 ± 1.1 s, p = 0.021). Sonographic findings showed smaller liver size (9.8 ± 1.4 vs. 12.0 ± 1.9 cm, p = 0.002), larger spleen size (128.2 ± 3.7 vs. 88.1 ± 1.6 mm, p = 0.002), and higher APRI scores (1.69 ± 1.65 vs. 0.28 ± 0.16, p = 0.011). On multivariate analysis, splenomegaly (aOR 8.45, 95% CI 3.21–22.28), elevated APRI (aOR 5.10, 95% CI 2.30–11.30), and thrombocytopenia (aOR 4.82, 95% CI 1.95–11.92) were associated with EV in the exploratory multivariate model, though confidence intervals were wide, reflecting the small sample size. Spleen length ≥ 120 mm demonstrated the highest area under the receiver operating characteristic curve (AUC 0.88; bootstrap-corrected 0.86). In an exploratory etiology-stratified analysis, APRI was significantly associated with EV in the cirrhosis subgroup ( n = 25) but not in the EHPVO subgroup ( n = 16). Conclusion: In this single-center exploratory study, splenomegaly, thrombocytopenia, and elevated APRI showed significant associations with the presence of EV in children with portal hypertension. These findings suggest that readily available clinical and laboratory parameters may have potential utility for risk stratification; however, the small sample size, high disease prevalence, and absence of external validation preclude definitive conclusions. Prospective multicenter studies with larger, etiology-stratified cohorts are needed to confirm these observations and establish reliable diagnostic thresholds.
- Open Access
- 21 April 2026
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 74 (1) , 40
Biomarkers of cardiac injury in infants of diabetic mothers and its relation to echocardiographic findings
Background: Infants of diabetic mothers (IDMs) are predisposed to transient hypertrophic cardiomyopathy and subclinical myocardial dysfunction. However, validated diagnostic cut-off values for cardiac biomarkers in this population are lacking, and the relationship between a panel of multiple biomarkers and advanced echocardiographic indices has not been systematically established. This study aimed to evaluate cardiac troponin-I (cTnI), B-type natriuretic peptide (BNP), and creatine kinase-MB (CK-MB) in IDMs, correlate them with conventional and advanced echocardiographic parameters, and derive ROC-based diagnostic cut-off values for detecting echocardiographically defined cardiac dysfunction. Methods: In this prospective cross-sectional study, 100 term IDMs and 50 healthy controls were enrolled. Maternal glycemic control was assessed using HbA1c. Neonatal serum cTnI, BNP, and CK-MB were measured within 24–48 h of birth. Comprehensive echocardiography included M-mode measurements, left ventricular mass (Devereux formula), fractional shortening, myocardial performance index (pulsed-wave tissue Doppler at the lateral mitral annulus), E/A ratio, and E/E′ ratio. ROC analysis determined optimal diagnostic cut-offs. Results: IDMs had significantly higher cTnI (0.42 ± 0.18 vs. 0.09 ± 0.03 ng/mL), BNP (165 ± 60 vs. 60 ± 20 pg/mL), and CK-MB (85 ± 25 vs. 45 ± 18 U/L) compared to controls (all p < 0.001). Echocardiography revealed increased interventricular septal thickness and left ventricular mass ( p < 0.001), preserved fractional shortening, but elevated MPI and E/E′ ratio indicating diastolic dysfunction (both p < 0.001). IDMs also had higher rates of transient tachypnea (18% vs. 4%, p = 0.02), feeding difficulties (15% vs. 2%, p = 0.01), and longer hospital stay (5.2 ± 2.1 vs. 3.1 ± 1.0 days, p < 0.001). Maternal HbA1c correlated strongly with cTnI ( r = 0.62) and BNP ( r = 0.54). ROC analysis identified cTnI as the most accurate biomarker (AUC = 0.89; cut-off > 0.12 ng/mL; sensitivity 88%, specificity 84%). Conclusions: Elevated cTnI, BNP, and CK-MB in IDMs reflect cardiac stress linked to maternal hyperglycemia. Population-specific biomarker cut-offs, particularly cTnI > 0.12 ng/mL, may facilitate non-invasive screening for subclinical cardiac dysfunction, guiding selective echocardiography use. These thresholds require prospective multicenter validation.
- 21 April 2026
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 74 (1) , 40
Open AccessBiomarkers of cardiac injury in infants of diabetic mothers and its relation to echocardiographic findings
Background: Infants of diabetic mothers (IDMs) are predisposed to transient hypertrophic cardiomyopathy and subclinical myocardial dysfunction. However, validated diagnostic cut-off values for cardiac biomarkers in this population are lacking, and the relationship between a panel of multiple biomarkers and advanced echocardiographic indices has not been systematically established. This study aimed to evaluate cardiac troponin-I (cTnI), B-type natriuretic peptide (BNP), and creatine kinase-MB (CK-MB) in IDMs, correlate them with conventional and advanced echocardiographic parameters, and derive ROC-based diagnostic cut-off values for detecting echocardiographically defined cardiac dysfunction. Methods: In this prospective cross-sectional study, 100 term IDMs and 50 healthy controls were enrolled. Maternal glycemic control was assessed using HbA1c. Neonatal serum cTnI, BNP, and CK-MB were measured within 24–48 h of birth. Comprehensive echocardiography included M-mode measurements, left ventricular mass (Devereux formula), fractional shortening, myocardial performance index (pulsed-wave tissue Doppler at the lateral mitral annulus), E/A ratio, and E/E′ ratio. ROC analysis determined optimal diagnostic cut-offs. Results: IDMs had significantly higher cTnI (0.42 ± 0.18 vs. 0.09 ± 0.03 ng/mL), BNP (165 ± 60 vs. 60 ± 20 pg/mL), and CK-MB (85 ± 25 vs. 45 ± 18 U/L) compared to controls (all p < 0.001). Echocardiography revealed increased interventricular septal thickness and left ventricular mass ( p < 0.001), preserved fractional shortening, but elevated MPI and E/E′ ratio indicating diastolic dysfunction (both p < 0.001). IDMs also had higher rates of transient tachypnea (18% vs. 4%, p = 0.02), feeding difficulties (15% vs. 2%, p = 0.01), and longer hospital stay (5.2 ± 2.1 vs. 3.1 ± 1.0 days, p < 0.001). Maternal HbA1c correlated strongly with cTnI ( r = 0.62) and BNP ( r = 0.54). ROC analysis identified cTnI as the most accurate biomarker (AUC = 0.89; cut-off > 0.12 ng/mL; sensitivity 88%, specificity 84%). Conclusions: Elevated cTnI, BNP, and CK-MB in IDMs reflect cardiac stress linked to maternal hyperglycemia. Population-specific biomarker cut-offs, particularly cTnI > 0.12 ng/mL, may facilitate non-invasive screening for subclinical cardiac dysfunction, guiding selective echocardiography use. These thresholds require prospective multicenter validation.
- Open Access
Early-Life Demographic Factors Shape Gut Microbiome Patterns Associated with Rotavirus Gastroenteritis Severity
Background: Rotavirus gastroenteritis (RVGE) remains a leading cause of severe infant diarrhea worldwide, with growing evidence supporting the role of the gut microbiome in modulating the disease. However, the interplay between early-life demographic factors, the gut microbiome, and their combined impact on RVGE clinical severity remains inadequately characterized, particularly in specific geographic populations. Aim: We aimed to investigate how demographic determinants shape gut microbiome composition and function in RVGE and how these features relate to clinical severity. Methods: In our comprehensive case–control study of 165 infants (120 RVGE cases and 45 healthy controls, aged 0–12 months), we utilized 16S rRNA sequencing combined with advanced statistical modeling and machine learning to investigate how demographic factors influence microbiome composition and clinical outcomes. Results: RVGE cases exhibited significantly reduced bacterial diversity (Kruskal–Wallis, Static = 14.85, p < 0.001) and distinct patterns, with community structure most strongly associated with dehydration severity (PERMANOVA; R2 = 0.15, p < 0.001). Substantial taxonomic alterations were identified characterized by depletion of beneficial commensals including Akkermansia (LDA score = 3.8, p < 0.001), Faecalibacterium (Random Forest AUC = 0.82, p < 0.001), and Bifidobacterium (r = −0.42 with breastfeeding, p < 0.001), alongside enrichment of inflammation-associated taxa such as Escherichia-Shigella (WBC; r = 0.49, p < 0.001, and CRP; r = 0.56, p < 0.001), Streptococcus (LDA score = 4.2, p < 0.001), and Staphylococcus. Proteobacteria was the top potential biomarker of severe outcomes (Random Forest AUC = 0.85), with abundance positively correlated with systemic inflammation (CRP: r = 0.51, p = 0.003). Functional predictions revealed increased lipopolysaccharide biosynthesis (ko00540) and reduced butanoate metabolism (ko00650, p < 0.001) in severe disease. Importantly, demographic factors significantly modulated clinical outcomes: cesarean-delivered, formula-fed infants presented the most dysbiotic profiles and experienced 3.2-fold longer hospitalization (95% CI: 1.8–5.6, p < 0.001) than vaginally delivered, breastfed infants did. Conclusions: Collectively, these findings demonstrate that early-life demographic factors potentially shape the gut microbiome composition and function, may influence RVGE severity and recovery trajectories, thus providing candidate biomarkers for risk stratification and identifying targets for microbiota-based interventions.
Open AccessEarly-Life Demographic Factors Shape Gut Microbiome Patterns Associated with Rotavirus Gastroenteritis Severity
Background: Rotavirus gastroenteritis (RVGE) remains a leading cause of severe infant diarrhea worldwide, with growing evidence supporting the role of the gut microbiome in modulating the disease. However, the interplay between early-life demographic factors, the gut microbiome, and their combined impact on RVGE clinical severity remains inadequately characterized, particularly in specific geographic populations. Aim: We aimed to investigate how demographic determinants shape gut microbiome composition and function in RVGE and how these features relate to clinical severity. Methods: In our comprehensive case–control study of 165 infants (120 RVGE cases and 45 healthy controls, aged 0–12 months), we utilized 16S rRNA sequencing combined with advanced statistical modeling and machine learning to investigate how demographic factors influence microbiome composition and clinical outcomes. Results: RVGE cases exhibited significantly reduced bacterial diversity (Kruskal–Wallis, Static = 14.85, p < 0.001) and distinct patterns, with community structure most strongly associated with dehydration severity (PERMANOVA; R2 = 0.15, p < 0.001). Substantial taxonomic alterations were identified characterized by depletion of beneficial commensals including Akkermansia (LDA score = 3.8, p < 0.001), Faecalibacterium (Random Forest AUC = 0.82, p < 0.001), and Bifidobacterium (r = −0.42 with breastfeeding, p < 0.001), alongside enrichment of inflammation-associated taxa such as Escherichia-Shigella (WBC; r = 0.49, p < 0.001, and CRP; r = 0.56, p < 0.001), Streptococcus (LDA score = 4.2, p < 0.001), and Staphylococcus. Proteobacteria was the top potential biomarker of severe outcomes (Random Forest AUC = 0.85), with abundance positively correlated with systemic inflammation (CRP: r = 0.51, p = 0.003). Functional predictions revealed increased lipopolysaccharide biosynthesis (ko00540) and reduced butanoate metabolism (ko00650, p < 0.001) in severe disease. Importantly, demographic factors significantly modulated clinical outcomes: cesarean-delivered, formula-fed infants presented the most dysbiotic profiles and experienced 3.2-fold longer hospitalization (95% CI: 1.8–5.6, p < 0.001) than vaginally delivered, breastfed infants did. Conclusions: Collectively, these findings demonstrate that early-life demographic factors potentially shape the gut microbiome composition and function, may influence RVGE severity and recovery trajectories, thus providing candidate biomarkers for risk stratification and identifying targets for microbiota-based interventions.